Non-Surgical Body Contouring: Treatments, Cost and Results

Body contouring is not one treatment.

It is the label med spas put on a group of devices and one injectable that each do a different, narrowly defined job — and the defined job is what matters, because the cleared wording names the use and the area, not "body contouring" in general.

What the category covers in practice: cryolipolysis (fat freezing), heat-based laser fat reduction, low-level laser circumference devices sold as "lipo laser", muscle-stimulation devices, radiofrequency body treatments and injectable fat reduction under the chin.

Some menus add cellulite devices, which are cleared for the appearance of cellulite rather than fat volume.

For each option side by side, see non-invasive body contouring treatments.

The wording to hold onto is what each clearance actually says.

CoolSculpting's current clearance covers "cold-assisted lipolysis" of named areas.

SculpSure's first clearance covered "non-invasive lipolysis of the flanks".

The low-level laser devices are cleared for "reduction of body circumference" as a non-invasive aesthetic treatment — a circumference claim, not a fat-loss or weight-loss one.

Allergan, CoolSculpting's maker, says its device is not a weight-loss treatment.

One regulatory distinction runs through the whole page: where this page names a device clearance, it is an FDA clearance (a 510(k) or De Novo), not FDA approval.

The exception among treatments still sold is Kybella, a prescription drug, which is FDA-approved — for one indication, moderate to severe under-chin fullness in adults.

Cold: cryolipolysis.

CoolSculpting was first cleared for fat reduction via De Novo DEN090002 on August 24, 2010, and the current CoolSculpting Elite clearance (K233732, September 12, 2024) covers cold-assisted lipolysis of the upper arm, bra fat, back fat, banana roll, thigh, abdomen and flank at a BMI of 30 or less, plus the submental (under the chin) and submandibular (under the jawline) areas at a BMI up to 46.2.

Localized cryolipolysis is a different product from the whole-body cryotherapy chambers at recovery studios, which have no FDA clearance for health claims.

Our CoolSculpting guide covers the device in depth.

Heat: laser lipolysis.

SculpSure (Cynosure) uses a 1060 nm laser and was first cleared on May 15, 2015 (K150230) for non-invasive lipolysis of the flanks in people with a BMI of 30 or less; later clearances expanded the areas.

What our research holds for SculpSure is the clearance wording, not trial figures we can quote — a gap worth knowing about when a menu promises percentages.

Muscle: HIFEM.

The original Emsculpt-type devices are powered muscle stimulators, cleared (K180813, June 14, 2018) to improve abdominal tone, strengthen the abdominal muscles and develop a firmer abdomen, and to strengthen, tone and firm the buttocks and thighs; later clearances added the arms and the calves.

Those clearances cover muscle only — they include no fat-reduction indication.

The fat-reduction indications belong to the radiofrequency-plus-HIFEM family marketed as Emsculpt NEO: cleared (K192224, December 5, 2019) for non-invasive lipolysis and circumference reduction of the abdomen, originally for skin types I to III, with later versions adding the thighs and skin types I to VI.

A 2023 clearance extended the family to the abdomen and thighs for skin types I to VI, the flanks for skin types I to IV, and the upper arms only for skin types II to III at a BMI of 30 or under.

BTL, the maker, says an Emsculpt NEO session runs 30 minutes and that the typical protocol is four sessions 5 to 10 days apart, for patients up to BMI 35.

Those are manufacturer figures — and note the BMI 35 line sits above the BMI 30-or-under limit written into the upper-arm clearance.

Low-level laser ("lipo laser"): devices such as Erchonia's Zerona are cleared only for the reduction of body circumference as a non-invasive aesthetic treatment — not for fat loss or weight loss.

The first was cleared via De Novo DEN090008 (August 24, 2010), and a current model, the Zerona VZ8 (K243811, January 10, 2025), is cleared for over-the-counter distribution.

Radiofrequency: the American Academy of Dermatology counts radiofrequency among the non-invasive fat-reduction options and lists 4 to 10 sessions as its typical count.

Here as with every family on this page, the specific device's cleared wording — not the menu name — is what tells you what it is cleared to do.

The cleared wording decides what a device can be used for, area by area.

The table reads each family's clearance at the level the labeling states it:

Cellulite deserves its own read, because the cleared claims differ in ways that matter.

Avéli's 2021 clearance covers temporary reduction in the appearance of cellulite on the buttocks and thighs of adult females, with data through three months.

Cellfina is cleared for long-term improvement, with data showing no significant reduction in benefit through five years.

Resonic is cleared for long-term improvement, supported by data up to 1 year.

The American Academy of Dermatology does not recommend cryolipolysis for cellulite.

One injectable is off the menu: QWO was an FDA-approved cellulite drug (approved July 6, 2020), but its maker announced on December 6, 2022 that it would cease production and sale, citing concerns about bruising and potential prolonged skin discoloration.

Under the chin is also where an approved drug sits: Kybella (deoxycholic acid) is FDA-approved only for moderate to severe fullness from submental fat in adults, and its label says it is not approved for fat outside the submental region and that such use is not recommended.

The label allows up to 6 single treatments at least 1 month apart.

Our Kybella guide covers the trials, the swelling and the cost.

Two limits are worth carrying into any consultation.

First, BMI limits are written into the cleared labeling — 30 or less for CoolSculpting's body areas, 30 or under for Emsculpt NEO's upper arms — while BTL's "up to BMI 35" line for Emsculpt NEO is the maker's protocol statement, not part of a clearance.

Second, ASPS says people who are pregnant or breastfeeding should not have nonsurgical fat reduction procedures — the procedures on its list are cryolipolysis, injection lipolysis, radiofrequency and laser lipolysis.

And if the goal is overall weight rather than specific areas, that is the territory of medical weight loss programs, not body contouring devices.

Start with the honest part: we could not confirm a national per-treatment price for any device on this page in the sources we checked.

The one national figure our research could confirm is the American Society of Plastic Surgeons' average cost of $1,157 for nonsurgical fat reduction — a category that includes cryolipolysis, Kybella, radiofrequency and laser lipolysis — which ASPS presents as its latest statistics.

Its limits matter: it is the average fee reported by ASPS member surgeons, not a med spa price, and ASPS says it excludes related expenses.

The ASPS page also does not date its statistics.

For the full pricing picture, see body contouring cost.

What drives the total is the plan: the areas treated and the number of sessions the provider's plan assumes.

The American Academy of Dermatology's typical counts give the shape of it — 2 sessions for cryolipolysis, 1 to 3 for ultrasound, 4 to 10 for radiofrequency — and BTL says its typical Emsculpt NEO protocol is four sessions.

Because no source we checked sets a standard session count per area, the written plan is the number to price.

Ask any quote what it assumes: which areas, how many sessions, and what a further session would cost.

One money note from outside the industry: IRS Publication 502 counts cosmetic procedures that improve appearance without promoting proper body function or treating disease as generally not deductible medical expenses, and it names liposuction as an example.

Whether any course of treatments could ever qualify is a question for a tax professional, not a med spa.

The shared timeline: the American Academy of Dermatology says device results can start as early as 3 weeks, with the full effect 3 to 6 months after the last treatment.

How long results then hold is the harder question, and the honest answer is that published long-term data are limited.

It also helps to know what "results" mean in this category, because the studies measure millimeters of fat layer and centimeters of waist, not pounds on a scale — a frame worth keeping when you read before-and-after galleries.

CoolSculpting's measured results live on its own page.

For muscle stimulation, a 2019 MRI study of 22 people who had four Emsculpt abdominal treatments reported average reductions of 18.6% in fat thickness and 10.4% in abdominal separation, a 15.4% increase in rectus abdominis thickness, and an average waist reduction of 3.8 cm at 2 months.

A 2020 follow-up scanned 21 people roughly a year after treatment and reported mean reductions of 14.6% in fat and 10.5% in diastasis recti, 19.1% muscle thickening, and no adverse events — with the authors' own caveat that durability needs verification.

These are small, uncontrolled studies, and study averages are not what any one person gets.

BTL advertises Emsculpt NEO results as "25% muscle growth" and "30% fat reduction" — asterisked, study-based averages from the maker, not an expected result.

For low-level laser devices, a 2025 systematic review found only three randomized controlled trials, with 160 participants in total: waist circumference fell by 2.48 cm with the active device versus 0.635 cm with a control, and the authors called the protocols varied and the long-term efficacy unclear.

For cellulite, the cleared claims themselves carry the time windows: Avéli's rest on data through three months; Cellfina's on data showing no significant reduction in benefit through five years; Resonic's on data up to 1 year.

For SculpSure, our research holds the clearance wording rather than efficacy figures we can quote — ask any provider what data exist for the device in their room.

The American Academy of Dermatology's summary of the whole non-invasive category is one line: the results are subtle — its image is that pants fit a little looser — while liposuction gives more dramatic results.

On the surgical price we have to be candid: ASPS's 2024 cost report could not be retrieved in our research.

A search summary of it describes surgeon's fees of $4,300 to $7,500 for liposuction — a surgeon's fee, which excludes anesthesia and facility costs — but we could not check the report itself, and a surgeon's fee is not a med spa price either.

Treat any liposuction or body-contouring figure you see online as a starting point for a written local quote, not as a number we verified.

Which fits depends on the area, your BMI against the cleared limits, the change you want and your health history — questions for the licensed provider you consult, not for a menu.

What the comparison does settle: non-surgical does not mean stronger, and subtle is what the evidence describes.

When you start comparing clinics, the legal frame is state law.

No federal law defines a "med spa"; whether one is regulated as a medical practice, and who may own it, is determined by each state's medical-practice, nursing and corporate-practice rules — and AmSpa, the trade association, positions med spas as medical practices.

Expect a "good faith exam" before a first treatment: in AmSpa's description, a physician, physician assistant or advanced practice nurse takes your medical history, performs an appropriate physical exam and creates the treatment order; an RN may assist but cannot generate the order.

AmSpa suggests repeating that exam when treatments change, when your health changes, or at least annually — the association's rule of thumb, not a statute.

The cleared wording travels with you: whatever device a clinic names, ask which clearance covers your area and your BMI, and ask who operates the device.

The checklist below works for every family on this page, and our how to choose a med spa guide goes wider — credentials, red flags and the questions that sort good rooms from bad ones.

A practice that answers these in the consultation is doing nothing unusual; a practice that will not put the plan and the price in writing has told you something too.

The treatment decision belongs with you and a licensed provider.